Answer
Somapacitan can decrease the conversion of cortisone to cortisol, potentially unmasking previously undiscovered central hypoadrenalism or making low glucocorticoid replacement doses ineffective.
Sources for this answer
- Sogroya 10mg/1.5 mL solution for injection in pre-filled penNovo Nordisk Limited · emc · SmPC §4.5 Interaction with other medicinal products · Version 2Document updated
Sources checked